Article(id=1327671943282668444, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327671856833868058, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2022.11.018, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1658937600000, receivedDateStr=2022-07-28, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794471258230, onlineDateStr=2026-11-12, pubDate=1668009600000, pubDateStr=2022-11-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794471258230, onlineIssueDateStr=2026-11-12, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794471258230, creator=13701087609, updateTime=1794471258230, updator=13701087609, issue=Issue{id=1327671856833868058, tenantId=1146029695717560320, journalId=1319690259887390882, year='2022', volume='53', issue='11', pageStart='1529', pageEnd='1670', issueExtLink='null', onlineDate='null', pubDate='1668009600000', pubDateStr='2022-11-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794471237619, creator='13701087609', updateTime=1794472094917, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1327675453114004391, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327671856833868058, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1327675453114004392, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1327671856833868058, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1634, endPage=1642, ext={EN=ArticleExt(id=1327671943471412125, articleId=1327671943282668444, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Extrapolation-based Clinical Trial Design Strategies for Pediatric Antiepileptic Drugs, columnId=null, journalTitle=Chinese Journal of Pharmaceuticals, columnName=null, runingTitle=null, highlight=null, articleAbstract=

Antiepileptic drugs(AED) are the cornerstone and first-choice of the treatment for childhood epilepsy. However, due to the difficulty of evaluating efficacy by randomized controlled trials in the pediatric population, the development of new AEDs for children is delayed. This paper reviews the evidence, history and current thoughts of applying extrapolation method into the development of pediatric AEDs. Besides, the extrapolation-based strategies for pediatric clinical trial design are also illustrated. The results show that the efficacy of drugs treating focal onset seizures(FOS) currently could be extrapolated from adults to pediatric patients 1 month of age and older. The pediatric extrapolation plans should include: the development of pediatric formulations, the rational design of pediatric pharmacokinetics(PK) study and long-term safety study, as well as model-informed dose selection for antiepileptic drugs in pediatrics.

, authors=Yuanyuan ZHENG, Guoxiang HAO, Yuee WU, Wei ZHAO*, authorsList=Yuanyuan ZHENG, Guoxiang HAO, Yuee WU, Wei ZHAO, authorCompany=null, correspAuthors=Wei ZHAO, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1327671944368993182, articleId=1327671943282668444, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=基于外推的抗癫痫药儿科临床研究策略, columnId=1327671857534316828, journalTitle=中国医药工业杂志, columnName=本期主题:儿童药创新研发与科学监管, runingTitle=null, highlight=null, articleAbstract=

抗癫痫药物(AED)是治疗儿童癫痫的基石和首选手段,然而在儿童人群中通过随机对照临床试验评价其有效性困难,造成儿童AED新药研发明显滞后。该研究综述了外推理念在儿童AED研发中应用的理论基础、发展历史和现状,以及基于外推理念的儿童AED临床研究策略。结果显示,局灶性癫痫发作(FOS)治疗药物的成人有效性向1个月以上儿童患者的外推已被接受。儿童外推计划应包括:儿童适宜性剂型的开发、儿童药动学(PK)研究和长期安全性研究的合理设计以及采用模型引导的方法筛选儿童剂量。

, authors=郑媛媛, 郝国祥, 吴月娥, 赵维*, authorsList=郑媛媛, 郝国祥, 吴月娥, 赵维, authorCompany=null, correspAuthors=赵维, authorNote=

郑媛媛(1998—),女,硕士研究生,专业方向:临床药学。

, correspAuthorsNote=
赵维(1982—),男,博士,教授,从事临床药学与临床药理学研究。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=4GxrMCTjcAoUGTeLIWsDZQ==, magXml=6Gkk4pV2B3ERaFMc/qGZkg==, pdfUrl=null, pdf=hARMXBfZGpcfNsLO3N0Ejg==, pdfFileSize=1640799, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=Ppomsn/JcnqINpOVMztS8A==, mapNumber=null, fund=null)}, authors=[Author(id=1327672168344826299, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672168483238333, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, authorId=1327672168344826299, language=EN, stringName=Yuanyuan ZHENG, firstName=Yuanyuan, middleName=null, lastName=ZHENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Medical Products Administration Key Lab. for Clinical Research and Evaluation of Innovative Drugs, Institute of Clinical Pharmacology, Dept. of Clinical Pharmacy, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672168541958590, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, authorId=1327672168344826299, language=CN, stringName=郑媛媛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=山东大学齐鲁医学院药学院临床药学系,临床药理研究所,国家药监局创新药物临床研究与评价重点实验室,山东 济南 250012, bio={"content":"

郑媛媛(1998—),女,硕士研究生,专业方向:临床药学。

"}, bioImg=null, bioContent=

郑媛媛(1998—),女,硕士研究生,专业方向:临床药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672168277717431, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, xref=null, ext=[AuthorCompanyExt(id=1327672168286106040, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, companyId=1327672168277717431, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Medical Products Administration Key Lab. for Clinical Research and Evaluation of Innovative Drugs, Institute of Clinical Pharmacology, Dept. of Clinical Pharmacy, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012), AuthorCompanyExt(id=1327672168290300345, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, companyId=1327672168277717431, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=山东大学齐鲁医学院药学院临床药学系,临床药理研究所,国家药监局创新药物临床研究与评价重点实验室,山东 济南 250012)])]), Author(id=1327672168604873152, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672168776839618, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, authorId=1327672168604873152, language=EN, stringName=Guoxiang HAO, firstName=Guoxiang, middleName=null, lastName=HAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Medical Products Administration Key Lab. for Clinical Research and Evaluation of Innovative Drugs, Institute of Clinical Pharmacology, Dept. of Clinical Pharmacy, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672170425201091, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, authorId=1327672168604873152, language=CN, stringName=郝国祥, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=山东大学齐鲁医学院药学院临床药学系,临床药理研究所,国家药监局创新药物临床研究与评价重点实验室,山东 济南 250012, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672168277717431, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, xref=null, ext=[AuthorCompanyExt(id=1327672168286106040, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, companyId=1327672168277717431, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Medical Products Administration Key Lab. for Clinical Research and Evaluation of Innovative Drugs, Institute of Clinical Pharmacology, Dept. of Clinical Pharmacy, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012), AuthorCompanyExt(id=1327672168290300345, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, companyId=1327672168277717431, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=山东大学齐鲁医学院药学院临床药学系,临床药理研究所,国家药监局创新药物临床研究与评价重点实验室,山东 济南 250012)])]), Author(id=1327672170496504261, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672170563613127, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, authorId=1327672170496504261, language=EN, stringName=Yuee WU, firstName=Yuee, middleName=null, lastName=WU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Medical Products Administration Key Lab. for Clinical Research and Evaluation of Innovative Drugs, Institute of Clinical Pharmacology, Dept. of Clinical Pharmacy, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672170639110600, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, authorId=1327672170496504261, language=CN, stringName=吴月娥, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=山东大学齐鲁医学院药学院临床药学系,临床药理研究所,国家药监局创新药物临床研究与评价重点实验室,山东 济南 250012, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672168277717431, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, xref=null, ext=[AuthorCompanyExt(id=1327672168286106040, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, companyId=1327672168277717431, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Medical Products Administration Key Lab. for Clinical Research and Evaluation of Innovative Drugs, Institute of Clinical Pharmacology, Dept. of Clinical Pharmacy, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012), AuthorCompanyExt(id=1327672168290300345, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, companyId=1327672168277717431, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=山东大学齐鲁医学院药学院临床药学系,临床药理研究所,国家药监局创新药物临床研究与评价重点实验室,山东 济南 250012)])]), Author(id=1327672170702025162, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhao4wei2@hotmail.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1327672170802688460, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, authorId=1327672170702025162, language=EN, stringName=Wei ZHAO, firstName=Wei, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=National Medical Products Administration Key Lab. for Clinical Research and Evaluation of Innovative Drugs, Institute of Clinical Pharmacology, Dept. of Clinical Pharmacy, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672170945294797, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, authorId=1327672170702025162, language=CN, stringName=赵维, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=山东大学齐鲁医学院药学院临床药学系,临床药理研究所,国家药监局创新药物临床研究与评价重点实验室,山东 济南 250012, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672168277717431, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, xref=null, ext=[AuthorCompanyExt(id=1327672168286106040, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, companyId=1327672168277717431, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Medical Products Administration Key Lab. for Clinical Research and Evaluation of Innovative Drugs, Institute of Clinical Pharmacology, Dept. of Clinical Pharmacy, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012), AuthorCompanyExt(id=1327672168290300345, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, companyId=1327672168277717431, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=山东大学齐鲁医学院药学院临床药学系,临床药理研究所,国家药监局创新药物临床研究与评价重点实验室,山东 济南 250012)])])], keywords=[Keyword(id=1327672171092095438, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, language=EN, orderNo=1, keyword=extrapolation), Keyword(id=1327672171167592911, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, language=EN, orderNo=2, keyword=antiepileptic drug), Keyword(id=1327672171230507472, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, language=EN, orderNo=3, keyword=pediatric population), Keyword(id=1327672171301810641, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, language=EN, orderNo=4, keyword=clinical trial), Keyword(id=1327672171377308114, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, language=EN, orderNo=5, keyword=focal onset seizures), Keyword(id=1327672171456999891, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, language=CN, orderNo=1, keyword=外推), Keyword(id=1327672171532497364, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, language=CN, orderNo=2, keyword=抗癫痫药), Keyword(id=1327672171603800533, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, language=CN, orderNo=3, keyword=儿童人群), Keyword(id=1327672171683492310, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, language=CN, orderNo=4, keyword=临床研究), Keyword(id=1327672171767378391, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, language=CN, orderNo=5, keyword=局灶性癫痫发作)], refs=[Reference(id=1327672172144865754, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=中国抗癫痫协会,临床诊疗指南:癫痫病分册(2015年修订版)[M].北京:人民卫生出版社,2015:11-90., articleTitle=null, refAbstract=null), Reference(id=1327672172216168923, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=GOGOU M, CROSS J H.Seizures and epilepsy in childhood [J].Continuum (Minneap Minn), 2022, 28(2):428-456., articleTitle=null, refAbstract=null), Reference(id=1327672172291666396, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=BEGHI E, GIUSSANI G, SANDER J W.The natural history and prognosis of epilepsy [J].Epileptic Disord,2015, 17(3): 243-253., articleTitle=null, refAbstract=null), Reference(id=1327672172354580957, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=HOLMES G L.Effect of seizures on the developing brain and cognition [J].Semin Pediatr Neurol, 2016, 23(2): 120-126., articleTitle=null, refAbstract=null), Reference(id=1327672172430078430, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=NEYENS L G, ALDENKAMP A P, MEINARDI H M.Prospective follow-up of intellectual development in children with a recent onset of epilepsy [J].Epilepsy Res, 1999,34(2/3): 85-90., articleTitle=null, refAbstract=null), Reference(id=1327672172488798687, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=DING D, ZHOU D, SANDER J W, et al.Epilepsy in China: major progress in the past two decades [J].Lancet Neurol,2021, 20(4): 316-326., articleTitle=null, refAbstract=null), Reference(id=1327672172555907552, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=PERUCCA P, SCHEFFER I E, KILEY M.The management of epilepsy in children and adults [J].Med J Aust, 2018,208(5): 226-233., articleTitle=null, refAbstract=null), Reference(id=1327672172648182241, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=National Institute fro Health and Care Excellence.Epilepsies in children young people and adults [EB/OL].(2022-04-27)[2022-09-03].https://www.nice.org.uk/guidance/ng217/resources/epilepsies-in-children-young-people-and-adults-pdf-66143780239813., articleTitle=null, refAbstract=null), Reference(id=1327672172740456930, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA.Guideline on clinical investigation of medicinal products in the treatment of epileptic disorders [EB/OL].(2010-07-22) [2022-07-27].https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-clinical-investigation-medicinal-products-treatment-epileptic-disorders-revision-2_en.pdf., articleTitle=null, refAbstract=null), Reference(id=1327672172820148707, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=LÖSCHER W, SCHMIDT D.Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma [J].Epilepsia, 2011, 52(4): 657-678., articleTitle=null, refAbstract=null), Reference(id=1327672172933394916, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=WADSWORTH I, JAKI T, SILLS G J, et al.Clinical drug development in epilepsy revisited: a proposal for a new paradigm streamlined using extrapolation [J].CNS Drugs,2016, 30(11): 1011-1017., articleTitle=null, refAbstract=null), Reference(id=1327672173025669605, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=ARZIMANOGLOU A, BEN-MENACHEM E, CRAMER J, et al.The evolution of antiepileptic drug development and regulation [J].Epileptic Disord, 2010, 12(1): 3-15., articleTitle=null, refAbstract=null), Reference(id=1327672173105361382, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=GAROFALO E.Obtaining pediatric indications for new anti-epileptic drugs: how and when [J].Epilepsy Res, 2006,68(1): 38-42., articleTitle=null, refAbstract=null), Reference(id=1327672173155693031, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Guidelines for the clinical evaluation of antiepileptic drugs (adults and children)[EB/OL].(1981-01-01) [2022-07-27].https://www.fda.gov/media/71165/download., articleTitle=null, refAbstract=null), Reference(id=1327672173222801896, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.成人用药数据外推至儿科人群的技术指导原则[EB/OL].(2017-05-18)[2022-07-27].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=836cb4dbe6962972b14a7030b6aae972., articleTitle=null, refAbstract=null), Reference(id=1327672174929883625, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=CHIRON C, DULAC O, PONS G.Antiepileptic drug development in children: considerations for a revisited strategy [J].Drugs, 2008, 68(1): 17-25., articleTitle=null, refAbstract=null), Reference(id=1327672175009575402, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=杨圣海,王珺,王立文,等,癫痫儿童抗癫痫药使用情况及超说明书用药的调查分析[J].中国医药导报,2018,15(11):45-48., articleTitle=null, refAbstract=null), Reference(id=1327672175101850091, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=PELLOCK J M, CARMAN W J, THYAGARAJAN V, et al.Efficacy of antiepileptic drugs in adults predicts efficacy in children: a systematic review [J].Neurology, 2012,79(14): 1482-1489., articleTitle=null, refAbstract=null), Reference(id=1327672175164764652, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=张慧敏,刘霭明,朱文烽,等.成人用药数据外推至儿科人群的科学决策过程和法规依据研究进展分析[J].中国临床药理学与治疗学,2019,24(1):49-56., articleTitle=null, refAbstract=null), Reference(id=1327672175227679213, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=SCHEFFER I E, BERKOVIC S, CAPOVILLA G, et al.ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology [J].Epilepsia, 2017, 58(4): 512-521., articleTitle=null, refAbstract=null), Reference(id=1327672175290593774, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA.Conclusions of the Paediatric Epilepsy Experts Group Meeting [EB/OL].(2010-04-29) [2022-07-27].https://www.ema.europa.eu/en/documents/other/conclusions-paediatric-epilepsy-experts-group-meeting_en.pdf., articleTitle=null, refAbstract=null), Reference(id=1327672175378674159, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=STAFSTROM C E, CARMANT L.Seizures and epilepsy: an overview for neuroscientists [J].Cold Spring Harb Perspect Med, 2015, 5(6): a022426., articleTitle=null, refAbstract=null), Reference(id=1327672175441588720, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=SWANN J W, SMITH K L, BRADY R J.Localized excitatory synaptic interactions mediate the sustained depolarization of electrographic seizures in developing hippocampus [J].J Neurosci, 1993, 13(11): 4680-4689., articleTitle=null, refAbstract=null), Reference(id=1327672175542252017, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=PELLOCK J M, ARZIMANOGLOU A, D’CRUZ O, et al.Extrapolating evidence of antiepileptic drug efficacy in adults to children ≥2 years of age with focal seizures: The case for disease similarity [J].Epilepsia, 2017, 58(10): 1686-1696., articleTitle=null, refAbstract=null), Reference(id=1327672175613555186, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=ARZIMANOGLOU A, D’CRUZ O, NORDLI D, et al.A review of the new antiepileptic drugs for focal-onset seizures in pediatrics: role of extrapolation [J].Paediatr Drugs,2018, 20(3): 249-264., articleTitle=null, refAbstract=null), Reference(id=1327672175680664051, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=TYZIO R, REPRESA A, JORQUERA I, et al.The establishment of GABAergic and glutamatergic synapses on CA1 pyramidal neurons is sequential and correlates with the development of the apical dendrite [J].J Neurosci, 1999,19(23): 10372-10382., articleTitle=null, refAbstract=null), Reference(id=1327672175756161524, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=MEHROTRA S, BHATTARAM A, KRUDYS K, et al.Extrapolation of efficacy from adults to pediatric patients of drugs for treatment of partial onset seizures: a regulatory perspective [J].Clin Pharmacol Ther, 2022, 112(4): 853-863., articleTitle=null, refAbstract=null), Reference(id=1327672175848436213, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Anon.Guidelines for clinical evaluation of antiepileptic drugs.Commission on Antiepileptic Drugs of the International League Against Epilepsy [J].Epilepsia, 1989,30(4): 400-408., articleTitle=null, refAbstract=null), Reference(id=1327672175982653942, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=SHERIDAN P H, JACOBS M P.The development of antiepileptic drugs for children.Report from the NIH workshop, Bethesda, Maryland, February 17-18, 1994 [J].Epilepsy Res, 1996, 23(1): 87-92., articleTitle=null, refAbstract=null), Reference(id=1327672176087511543, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=KATZ R.FDA update [J].Epilepsy Res, 2006, 68(1): 85-94., articleTitle=null, refAbstract=null), Reference(id=1327672176150426104, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Clinical review for TOPAMAX [EB/OL].(1999-07-23) [2022-07-27].https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/20505S1_Topamax.cfm., articleTitle=null, refAbstract=null), Reference(id=1327672176221729273, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Clinical review for NEURONTIN [EB/OL].(2000-10-12) [2022-07-27].https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/21-216_20-235S15_20-882S2_21-129S5_Neurontin.cfm., articleTitle=null, refAbstract=null), Reference(id=1327672176284643834, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Clinical review for TRILEPTAL [EB/OL].(2000-01-14) [2022-07-27].https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/21-014_Trileptal.cfm., articleTitle=null, refAbstract=null), Reference(id=1327672176402084347, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Label of LAMICTAL [EB/OL].(2003-01-17)[2022-07-27].https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/020241s008lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1327672176469193212, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Label of KEPPRA [EB/OL].(2005-06-21) [2022-07-27].https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021035s040,021505s007lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1327672176532107774, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=国家食品药品监督管理局.癫痫治疗药物临床研究试验技术指导原则.[EB/OL].(2012-05-15) [2022-07-27].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=10e222c5cf0efc9759ce3853c613a6d0., articleTitle=null, refAbstract=null), Reference(id=1327672176645353983, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Cross-discipline team leader review for APTIOM.[EB/OL].(2017-09-13) [2022-07-27].https://www.fda.gov/media/109082/download., articleTitle=null, refAbstract=null), Reference(id=1327672176750211584, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Drugs for treatment of partial onset seizures: full extrapolation of efficacy from adults to pediatric patients 4 years of age and older guidance for industry(draft guidance)[EB/OL].(2018-04-18) [2022-07-27].https://www.regulations.gov/document/FDA-2018-D-0178-0002., articleTitle=null, refAbstract=null), Reference(id=1327672176817320449, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Drugs for treatment of partial onset seizures: full extrapolation of efficacy from adults to pediatric patients 2 years of age and older guidance for industry [EB/OL].(2019-09-06) [2022-07-27] https://www.fda.gov/media/130449/download., articleTitle=null, refAbstract=null), Reference(id=1327672176884429314, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=PRESSLER R M, CILIO M R, MIZRAHI E M, et al.The ILAE classification of seizures and the epilepsies: modification for seizures in the neonate.Position paper by the ILAE Task Force on Neonatal Seizures [J].Epilepsia,2021, 62(3): 615-628., articleTitle=null, refAbstract=null), Reference(id=1327672177010258435, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=Epilepsy Foundation.Infantile seizure and innovative data capture, including electronic seizure diaries.2020, Research Roundtable for Epilepsy(RRE)[EB/OL].(2020-05)[2022-07-27].https://www.epilepsy.com/sites/default/files/atoms/files/2020%20RRE%20Summary.pdf., articleTitle=null, refAbstract=null), Reference(id=1327672177094144516, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Extrapolation of adult efficacy data leads to pediatric indications for 4 seizure drugs [EB/OL].(2018-09) [2022-07-17] https://www.fda.gov/media/125463/download., articleTitle=null, refAbstract=null), Reference(id=1327672177178030597, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Package insert for VIMPAT [EB/OL].(2021-10-14)[2022-07-27].https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022253s049,022254s039,022255s031lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1327672177245139462, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Clinical review for BRIVIACT [EB/OL].(2021-08-27)[2022-07-27].https://www.fda.gov/media/152421/download., articleTitle=null, refAbstract=null), Reference(id=1327672177329025543, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Package insert for LYRICA [EB/OL].(2019-05-23)[2022-07-27].https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021446s036,022488s014lbl.pdf., articleTitle=null, refAbstract=null), Reference(id=1327672177400328712, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.儿童用药(化学药品)药学开发指导原则(试行)[EB/OL].(2020-12-31)[2022-07-27].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=b24aa57426796f1624dff698b233ba05., articleTitle=null, refAbstract=null), Reference(id=1327672177471631881, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=KRAUSS G, BEN-MENACHEM E, MAMENISKIENE R, et al.Intravenous lacosamide as short-term replacement for oral lacosamide in partial-onset seizures [J].Epilepsia,2010, 51(6): 951-957., articleTitle=null, refAbstract=null), Reference(id=1327672177551323658, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.儿科人群药代动力学研究技术指导原则[EB/OL].(2014-07-11) [2022-07-27].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=d70358ce5fa15ef1f567e1a0837b9de1., articleTitle=null, refAbstract=null), Reference(id=1327672177631015435, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=SUNKARANENI S, LUDWIG E, FIEDLER-KELLY J, et al.Modeling and simulations to support dose selection for eslicarbazepine acetate therapy in pediatric patients with partial-onset seizures [J].J Pharmacokinet Pharmacodyn,2018, 45(4): 649-658., articleTitle=null, refAbstract=null), Reference(id=1327672179325514252, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=MULUGETA Y, BARRETT J S, NELSON R, et al.Exposure matching for extrapolation of efficacy in pediatric drug development [J].J Clin Pharmacol, 2016, 56(11):1326-1334., articleTitle=null, refAbstract=null)], funds=[Fund(id=1327672171889013208, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, awardId=82173897, language=CN, fundingSource=国家自然科学基金面上项目(82173897), fundOrder=null, country=null), Fund(id=1327672171951927769, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, awardId=2020ZG25, language=CN, fundingSource=国家级一流本科专业建设点“临床药学”(2020ZG25), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1327672168277717431, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, xref=null, ext=[AuthorCompanyExt(id=1327672168286106040, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, companyId=1327672168277717431, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Medical Products Administration Key Lab. for Clinical Research and Evaluation of Innovative Drugs, Institute of Clinical Pharmacology, Dept. of Clinical Pharmacy, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012), AuthorCompanyExt(id=1327672168290300345, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, companyId=1327672168277717431, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=山东大学齐鲁医学院药学院临床药学系,临床药理研究所,国家药监局创新药物临床研究与评价重点实验室,山东 济南 250012)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2022.11.018, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2022.11.018, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2022.11.018, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2022.11.018, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1668009600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
基于外推的抗癫痫药儿科临床研究策略
郑媛媛 , 郝国祥 , 吴月娥 , 赵维 *
中国医药工业杂志 | 本期主题:儿童药创新研发与科学监管 2022,53(11): 1634-1642
收起
收藏切换
中国医药工业杂志 |本期主题:儿童药创新研发与科学监管 2022 , 53 (11) : 1634 -1642
基于外推的抗癫痫药儿科临床研究策略
全屏
[Author(id=1327672168344826299, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672168483238333, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, authorId=1327672168344826299, language=EN, stringName=Yuanyuan ZHENG, firstName=Yuanyuan, middleName=null, lastName=ZHENG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Medical Products Administration Key Lab. for Clinical Research and Evaluation of Innovative Drugs, Institute of Clinical Pharmacology, Dept. of Clinical Pharmacy, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672168541958590, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, authorId=1327672168344826299, language=CN, stringName=郑媛媛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=山东大学齐鲁医学院药学院临床药学系,临床药理研究所,国家药监局创新药物临床研究与评价重点实验室,山东 济南 250012, bio={"content":"

郑媛媛(1998—),女,硕士研究生,专业方向:临床药学。

"}, bioImg=null, bioContent=

郑媛媛(1998—),女,硕士研究生,专业方向:临床药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672168277717431, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, xref=null, ext=[AuthorCompanyExt(id=1327672168286106040, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, companyId=1327672168277717431, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Medical Products Administration Key Lab. for Clinical Research and Evaluation of Innovative Drugs, Institute of Clinical Pharmacology, Dept. of Clinical Pharmacy, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012), AuthorCompanyExt(id=1327672168290300345, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, companyId=1327672168277717431, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=山东大学齐鲁医学院药学院临床药学系,临床药理研究所,国家药监局创新药物临床研究与评价重点实验室,山东 济南 250012)])]), Author(id=1327672168604873152, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672168776839618, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, authorId=1327672168604873152, language=EN, stringName=Guoxiang HAO, firstName=Guoxiang, middleName=null, lastName=HAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Medical Products Administration Key Lab. for Clinical Research and Evaluation of Innovative Drugs, Institute of Clinical Pharmacology, Dept. of Clinical Pharmacy, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672170425201091, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, authorId=1327672168604873152, language=CN, stringName=郝国祥, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=山东大学齐鲁医学院药学院临床药学系,临床药理研究所,国家药监局创新药物临床研究与评价重点实验室,山东 济南 250012, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672168277717431, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, xref=null, ext=[AuthorCompanyExt(id=1327672168286106040, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, companyId=1327672168277717431, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Medical Products Administration Key Lab. for Clinical Research and Evaluation of Innovative Drugs, Institute of Clinical Pharmacology, Dept. of Clinical Pharmacy, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012), AuthorCompanyExt(id=1327672168290300345, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, companyId=1327672168277717431, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=山东大学齐鲁医学院药学院临床药学系,临床药理研究所,国家药监局创新药物临床研究与评价重点实验室,山东 济南 250012)])]), Author(id=1327672170496504261, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1327672170563613127, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, authorId=1327672170496504261, language=EN, stringName=Yuee WU, firstName=Yuee, middleName=null, lastName=WU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Medical Products Administration Key Lab. for Clinical Research and Evaluation of Innovative Drugs, Institute of Clinical Pharmacology, Dept. of Clinical Pharmacy, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672170639110600, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, authorId=1327672170496504261, language=CN, stringName=吴月娥, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=山东大学齐鲁医学院药学院临床药学系,临床药理研究所,国家药监局创新药物临床研究与评价重点实验室,山东 济南 250012, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672168277717431, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, xref=null, ext=[AuthorCompanyExt(id=1327672168286106040, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, companyId=1327672168277717431, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Medical Products Administration Key Lab. for Clinical Research and Evaluation of Innovative Drugs, Institute of Clinical Pharmacology, Dept. of Clinical Pharmacy, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012), AuthorCompanyExt(id=1327672168290300345, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, companyId=1327672168277717431, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=山东大学齐鲁医学院药学院临床药学系,临床药理研究所,国家药监局创新药物临床研究与评价重点实验室,山东 济南 250012)])]), Author(id=1327672170702025162, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhao4wei2@hotmail.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1327672170802688460, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, authorId=1327672170702025162, language=EN, stringName=Wei ZHAO, firstName=Wei, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=National Medical Products Administration Key Lab. for Clinical Research and Evaluation of Innovative Drugs, Institute of Clinical Pharmacology, Dept. of Clinical Pharmacy, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1327672170945294797, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, authorId=1327672170702025162, language=CN, stringName=赵维, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=山东大学齐鲁医学院药学院临床药学系,临床药理研究所,国家药监局创新药物临床研究与评价重点实验室,山东 济南 250012, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1327672168277717431, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, xref=null, ext=[AuthorCompanyExt(id=1327672168286106040, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, companyId=1327672168277717431, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Medical Products Administration Key Lab. for Clinical Research and Evaluation of Innovative Drugs, Institute of Clinical Pharmacology, Dept. of Clinical Pharmacy, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012), AuthorCompanyExt(id=1327672168290300345, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1327671943282668444, companyId=1327672168277717431, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=山东大学齐鲁医学院药学院临床药学系,临床药理研究所,国家药监局创新药物临床研究与评价重点实验室,山东 济南 250012)])])]
郑媛媛, 郝国祥, 吴月娥, 赵维*
作者信息
  • 山东大学齐鲁医学院药学院临床药学系,临床药理研究所,国家药监局创新药物临床研究与评价重点实验室,山东 济南 250012
通讯作者:
赵维(1982—),男,博士,教授,从事临床药学与临床药理学研究。E-mail:
作者简介:

郑媛媛(1998—),女,硕士研究生,专业方向:临床药学。

Extrapolation-based Clinical Trial Design Strategies for Pediatric Antiepileptic Drugs
Yuanyuan ZHENG, Guoxiang HAO, Yuee WU, Wei ZHAO*
Affiliations
  • National Medical Products Administration Key Lab. for Clinical Research and Evaluation of Innovative Drugs, Institute of Clinical Pharmacology, Dept. of Clinical Pharmacy, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012
出版时间: 2022-11-10 doi: 10.16522/j.cnki.cjph.2022.11.018
文章导航
收藏切换

抗癫痫药物(AED)是治疗儿童癫痫的基石和首选手段,然而在儿童人群中通过随机对照临床试验评价其有效性困难,造成儿童AED新药研发明显滞后。该研究综述了外推理念在儿童AED研发中应用的理论基础、发展历史和现状,以及基于外推理念的儿童AED临床研究策略。结果显示,局灶性癫痫发作(FOS)治疗药物的成人有效性向1个月以上儿童患者的外推已被接受。儿童外推计划应包括:儿童适宜性剂型的开发、儿童药动学(PK)研究和长期安全性研究的合理设计以及采用模型引导的方法筛选儿童剂量。

外推  /  抗癫痫药  /  儿童人群  /  临床研究  /  局灶性癫痫发作

Antiepileptic drugs(AED) are the cornerstone and first-choice of the treatment for childhood epilepsy. However, due to the difficulty of evaluating efficacy by randomized controlled trials in the pediatric population, the development of new AEDs for children is delayed. This paper reviews the evidence, history and current thoughts of applying extrapolation method into the development of pediatric AEDs. Besides, the extrapolation-based strategies for pediatric clinical trial design are also illustrated. The results show that the efficacy of drugs treating focal onset seizures(FOS) currently could be extrapolated from adults to pediatric patients 1 month of age and older. The pediatric extrapolation plans should include: the development of pediatric formulations, the rational design of pediatric pharmacokinetics(PK) study and long-term safety study, as well as model-informed dose selection for antiepileptic drugs in pediatrics.

extrapolation  /  antiepileptic drug  /  pediatric population  /  clinical trial  /  focal onset seizures
郑媛媛, 郝国祥, 吴月娥, 赵维. 基于外推的抗癫痫药儿科临床研究策略. 中国医药工业杂志, 2022 , 53 (11) : 1634 -1642 . DOI: 10.16522/j.cnki.cjph.2022.11.018
Yuanyuan ZHENG, Guoxiang HAO, Yuee WU, Wei ZHAO. Extrapolation-based Clinical Trial Design Strategies for Pediatric Antiepileptic Drugs[J]. Chinese Journal of Pharmaceuticals, 2022 , 53 (11) : 1634 -1642 . DOI: 10.16522/j.cnki.cjph.2022.11.018
  • 国家自然科学基金面上项目(82173897)
  • 国家级一流本科专业建设点“临床药学”(2020ZG25)
参考文献 引证文献
排序方式:
[1]
中国抗癫痫协会,临床诊疗指南:癫痫病分册(2015年修订版)[M].北京:人民卫生出版社,2015:11-90.
[2]
GOGOU M, CROSS J H.Seizures and epilepsy in childhood [J].Continuum (Minneap Minn), 2022, 28(2):428-456.
[3]
BEGHI E, GIUSSANI G, SANDER J W.The natural history and prognosis of epilepsy [J].Epileptic Disord,2015, 17(3): 243-253.
[4]
HOLMES G L.Effect of seizures on the developing brain and cognition [J].Semin Pediatr Neurol, 2016, 23(2): 120-126.
[5]
NEYENS L G, ALDENKAMP A P, MEINARDI H M.Prospective follow-up of intellectual development in children with a recent onset of epilepsy [J].Epilepsy Res, 1999,34(2/3): 85-90.
[6]
DING D, ZHOU D, SANDER J W, et al.Epilepsy in China: major progress in the past two decades [J].Lancet Neurol,2021, 20(4): 316-326.
[7]
PERUCCA P, SCHEFFER I E, KILEY M.The management of epilepsy in children and adults [J].Med J Aust, 2018,208(5): 226-233.
[8]
National Institute fro Health and Care Excellence.Epilepsies in children young people and adults [EB/OL].(2022-04-27)[2022-09-03].https://www.nice.org.uk/guidance/ng217/resources/epilepsies-in-children-young-people-and-adults-pdf-66143780239813.
[9]
EMA.Guideline on clinical investigation of medicinal products in the treatment of epileptic disorders [EB/OL].(2010-07-22) [2022-07-27].https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-clinical-investigation-medicinal-products-treatment-epileptic-disorders-revision-2_en.pdf.
[10]
LÖSCHER W, SCHMIDT D.Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma [J].Epilepsia, 2011, 52(4): 657-678.
[11]
WADSWORTH I, JAKI T, SILLS G J, et al.Clinical drug development in epilepsy revisited: a proposal for a new paradigm streamlined using extrapolation [J].CNS Drugs,2016, 30(11): 1011-1017.
[12]
ARZIMANOGLOU A, BEN-MENACHEM E, CRAMER J, et al.The evolution of antiepileptic drug development and regulation [J].Epileptic Disord, 2010, 12(1): 3-15.
[13]
GAROFALO E.Obtaining pediatric indications for new anti-epileptic drugs: how and when [J].Epilepsy Res, 2006,68(1): 38-42.
[14]
FDA.Guidelines for the clinical evaluation of antiepileptic drugs (adults and children)[EB/OL].(1981-01-01) [2022-07-27].https://www.fda.gov/media/71165/download.
[15]
国家药品监督管理局药品审评中心.成人用药数据外推至儿科人群的技术指导原则[EB/OL].(2017-05-18)[2022-07-27].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=836cb4dbe6962972b14a7030b6aae972.
[16]
CHIRON C, DULAC O, PONS G.Antiepileptic drug development in children: considerations for a revisited strategy [J].Drugs, 2008, 68(1): 17-25.
[17]
杨圣海,王珺,王立文,等,癫痫儿童抗癫痫药使用情况及超说明书用药的调查分析[J].中国医药导报,2018,15(11):45-48.
[18]
PELLOCK J M, CARMAN W J, THYAGARAJAN V, et al.Efficacy of antiepileptic drugs in adults predicts efficacy in children: a systematic review [J].Neurology, 2012,79(14): 1482-1489.
[19]
张慧敏,刘霭明,朱文烽,等.成人用药数据外推至儿科人群的科学决策过程和法规依据研究进展分析[J].中国临床药理学与治疗学,2019,24(1):49-56.
[20]
SCHEFFER I E, BERKOVIC S, CAPOVILLA G, et al.ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology [J].Epilepsia, 2017, 58(4): 512-521.
[21]
EMA.Conclusions of the Paediatric Epilepsy Experts Group Meeting [EB/OL].(2010-04-29) [2022-07-27].https://www.ema.europa.eu/en/documents/other/conclusions-paediatric-epilepsy-experts-group-meeting_en.pdf.
[22]
STAFSTROM C E, CARMANT L.Seizures and epilepsy: an overview for neuroscientists [J].Cold Spring Harb Perspect Med, 2015, 5(6): a022426.
[23]
SWANN J W, SMITH K L, BRADY R J.Localized excitatory synaptic interactions mediate the sustained depolarization of electrographic seizures in developing hippocampus [J].J Neurosci, 1993, 13(11): 4680-4689.
[24]
PELLOCK J M, ARZIMANOGLOU A, D’CRUZ O, et al.Extrapolating evidence of antiepileptic drug efficacy in adults to children ≥2 years of age with focal seizures: The case for disease similarity [J].Epilepsia, 2017, 58(10): 1686-1696.
[25]
ARZIMANOGLOU A, D’CRUZ O, NORDLI D, et al.A review of the new antiepileptic drugs for focal-onset seizures in pediatrics: role of extrapolation [J].Paediatr Drugs,2018, 20(3): 249-264.
[26]
TYZIO R, REPRESA A, JORQUERA I, et al.The establishment of GABAergic and glutamatergic synapses on CA1 pyramidal neurons is sequential and correlates with the development of the apical dendrite [J].J Neurosci, 1999,19(23): 10372-10382.
[27]
MEHROTRA S, BHATTARAM A, KRUDYS K, et al.Extrapolation of efficacy from adults to pediatric patients of drugs for treatment of partial onset seizures: a regulatory perspective [J].Clin Pharmacol Ther, 2022, 112(4): 853-863.
[28]
Anon.Guidelines for clinical evaluation of antiepileptic drugs.Commission on Antiepileptic Drugs of the International League Against Epilepsy [J].Epilepsia, 1989,30(4): 400-408.
[29]
SHERIDAN P H, JACOBS M P.The development of antiepileptic drugs for children.Report from the NIH workshop, Bethesda, Maryland, February 17-18, 1994 [J].Epilepsy Res, 1996, 23(1): 87-92.
[30]
KATZ R.FDA update [J].Epilepsy Res, 2006, 68(1): 85-94.
[31]
FDA.Clinical review for TOPAMAX [EB/OL].(1999-07-23) [2022-07-27].https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/20505S1_Topamax.cfm.
[32]
FDA.Clinical review for NEURONTIN [EB/OL].(2000-10-12) [2022-07-27].https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/21-216_20-235S15_20-882S2_21-129S5_Neurontin.cfm.
[33]
FDA.Clinical review for TRILEPTAL [EB/OL].(2000-01-14) [2022-07-27].https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/21-014_Trileptal.cfm.
[34]
FDA.Label of LAMICTAL [EB/OL].(2003-01-17)[2022-07-27].https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/020241s008lbl.pdf.
[35]
FDA.Label of KEPPRA [EB/OL].(2005-06-21) [2022-07-27].https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021035s040,021505s007lbl.pdf.
[36]
国家食品药品监督管理局.癫痫治疗药物临床研究试验技术指导原则.[EB/OL].(2012-05-15) [2022-07-27].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=10e222c5cf0efc9759ce3853c613a6d0.
[37]
FDA.Cross-discipline team leader review for APTIOM.[EB/OL].(2017-09-13) [2022-07-27].https://www.fda.gov/media/109082/download.
[38]
FDA.Drugs for treatment of partial onset seizures: full extrapolation of efficacy from adults to pediatric patients 4 years of age and older guidance for industry(draft guidance)[EB/OL].(2018-04-18) [2022-07-27].https://www.regulations.gov/document/FDA-2018-D-0178-0002.
[39]
FDA.Drugs for treatment of partial onset seizures: full extrapolation of efficacy from adults to pediatric patients 2 years of age and older guidance for industry [EB/OL].(2019-09-06) [2022-07-27] https://www.fda.gov/media/130449/download.
[40]
PRESSLER R M, CILIO M R, MIZRAHI E M, et al.The ILAE classification of seizures and the epilepsies: modification for seizures in the neonate.Position paper by the ILAE Task Force on Neonatal Seizures [J].Epilepsia,2021, 62(3): 615-628.
[41]
Epilepsy Foundation.Infantile seizure and innovative data capture, including electronic seizure diaries.2020, Research Roundtable for Epilepsy(RRE)[EB/OL].(2020-05)[2022-07-27].https://www.epilepsy.com/sites/default/files/atoms/files/2020%20RRE%20Summary.pdf.
[42]
FDA.Extrapolation of adult efficacy data leads to pediatric indications for 4 seizure drugs [EB/OL].(2018-09) [2022-07-17] https://www.fda.gov/media/125463/download.
[43]
FDA.Package insert for VIMPAT [EB/OL].(2021-10-14)[2022-07-27].https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022253s049,022254s039,022255s031lbl.pdf.
[44]
FDA.Clinical review for BRIVIACT [EB/OL].(2021-08-27)[2022-07-27].https://www.fda.gov/media/152421/download.
[45]
FDA.Package insert for LYRICA [EB/OL].(2019-05-23)[2022-07-27].https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021446s036,022488s014lbl.pdf.
[46]
国家药品监督管理局药品审评中心.儿童用药(化学药品)药学开发指导原则(试行)[EB/OL].(2020-12-31)[2022-07-27].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=b24aa57426796f1624dff698b233ba05.
[47]
KRAUSS G, BEN-MENACHEM E, MAMENISKIENE R, et al.Intravenous lacosamide as short-term replacement for oral lacosamide in partial-onset seizures [J].Epilepsia,2010, 51(6): 951-957.
[48]
国家药品监督管理局药品审评中心.儿科人群药代动力学研究技术指导原则[EB/OL].(2014-07-11) [2022-07-27].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=d70358ce5fa15ef1f567e1a0837b9de1.
[49]
SUNKARANENI S, LUDWIG E, FIEDLER-KELLY J, et al.Modeling and simulations to support dose selection for eslicarbazepine acetate therapy in pediatric patients with partial-onset seizures [J].J Pharmacokinet Pharmacodyn,2018, 45(4): 649-658.
[50]
MULUGETA Y, BARRETT J S, NELSON R, et al.Exposure matching for extrapolation of efficacy in pediatric drug development [J].J Clin Pharmacol, 2016, 56(11):1326-1334.
2022年第53卷第11期
87
19
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2022.11.018
  • 接收时间:2022-07-28
  • 首发时间:2026-11-12
  • 出版时间:2022-11-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2022-07-28
基金
国家自然科学基金面上项目(82173897)
国家级一流本科专业建设点“临床药学”(2020ZG25)
作者信息
    山东大学齐鲁医学院药学院临床药学系,临床药理研究所,国家药监局创新药物临床研究与评价重点实验室,山东 济南 250012

通讯作者:

赵维(1982—),男,博士,教授,从事临床药学与临床药理学研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2022.11.018
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏